Dr. Christiane Hampe, PhD, has been awarded an NIH R01 for her project entitled “Islet Cell Membrane Antibodies in Diabetes”. The goals of this research are a) to investigate anti-idiotypic antibodies (anti-Id) directed against autoantibodies to glutamate decarboxylase (GAD65Ab) in human Type 1 Diabetes (T1D), and b) to develop anti-Id as a therapeutic tool for the elimination of GAD65-specific B lymphocytes. The results from this project will be crucial for the further development of a novel preventative therapy. Dr. Hampe is Associate Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition.